The Influenza Virus Neuraminidase as a Vaccine Antigen and the Potential of Neuraminidase Antibodies to Protect Against Infection
<p> The influenza virus continues to cause significant morbidity and mortality in humans, resulting in up to 50,000 deaths per year in the United States. Annual vaccination remains the recommended prophylaxis for influenza. However, vaccines must be reformulated to account for antigenic drift...
| Main Author: | |
|---|---|
| Language: | EN |
| Published: |
Icahn School of Medicine at Mount Sinai
2018
|
| Subjects: | |
| Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=10746696 |